ICU Medical Earnings: Here’s Why Investors Don’t Like These Results

  Google+ | + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

ICU Medical, Inc. (NASDAQ:ICUI) delivered a profit and missed Wall Street’s expectations, AND came up short on beating the revenue expectation. The revenue miss is a negative sign to shareholders seeking high growth out of the company. Shares are down 8.08%.

ICU Medical, Inc. Earnings Cheat Sheet

Results: Adjusted Earnings Per Share decreased 23.81% to $0.48 in the quarter versus EPS of $0.63 in the year-earlier quarter.

Revenue: Rose 1.84% to $78.7 million from the year-earlier quarter.

Actual vs. Wall St. Expectations: ICU Medical, Inc. reported adjusted EPS income of $0.48 per share. By that measure, the company missed the mean analyst estimate of $0.66. It missed the average revenue estimate of $83.44 million.

Quoting Management: Scott Lamb, ICU Medical’s Chief Financial Officer, said, “Our top-line performance during the quarter was highlighted by continued growth in oncology which was offset by a decrease in critical care. International sales were up 4.4%, while domestic sales increased 0.8% year over year.”

Key Stats (on next page)…

More Articles About:

To contact the reporter on this story: To contact the editor responsible for this story:

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business